Position in PFE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,123,741
-$186,275 QoQ
Shares Held
46,667
+0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,265
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRANKLIN STREET ADVISORS INC /NC holds $55,471,815 across 7 Drug Manufacturers - General names. PFE ranks #5 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
181,638 | $45,707,386 | |
| 2 | JNJ |
Johnson & Johnson
|
19,450 | $4,939,716 | |
| 3 | AMGN |
Amgen Inc
|
3,408 | $1,234,104 | |
| 4 | LLY |
ELI LILLY & Co
|
1,009 | $1,210,224 | |
| 5 | PFE |
Pfizer Inc
This page
|
46,667 | $1,123,741 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,476 | $944,517 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,417 | $312,127 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,123,741 | 46,667 | Shares | Defined | 2026-07-09 | |
| 2026-03-31 | $1,310,016 | 46,653 | Shares | Defined | 2026-04-10 | |
| 2025-12-31 | $1,155,459 | 46,404 | Shares | Defined | 2026-01-21 | |
| 2025-09-30 | $1,180,513 | 46,331 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $1,329,103 | 54,831 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $1,093,750 | 43,163 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $1,144,849 | 43,153 | Shares | Defined | 2025-01-10 | |
| 2024-09-30 | $1,630,537 | 56,342 | Shares | Defined | 2024-10-09 | |
| 2024-06-30 | $1,194,718 | 42,699 | Shares | Defined | 2024-07-18 | |
| 2024-03-31 | $1,219,446 | 43,944 | Shares | Defined | 2024-04-15 | |
| 2023-12-31 | $1,280,060 | 44,462 | Shares | Defined | 2024-01-18 | |
| 2023-09-30 | $1,471,587 | 44,365 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $1,643,117 | 44,796 | Shares | Defined | 2023-07-13 | |
| 2023-03-31 | $1,335,139 | 32,724 | Shares | Defined | 2023-04-12 | |
| 2022-12-31 | $1,940,715 | 37,875 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $1,707,077 | 39,010 | Shares | Defined | 2022-10-11 | |
| 2022-06-30 | $2,030,509 | 38,728 | Shares | Defined | 2022-07-13 | |
| 2022-03-31 | $4,245,761 | 82,012 | Shares | Defined | 2022-04-18 | |
| 2021-12-31 | $6,812,185 | 115,363 | Shares | Defined | 2022-01-26 | |
| 2021-09-30 | $4,765,551 | 110,801 | Shares | Defined | 2021-10-22 | |
| 2021-06-30 | $4,415,055 | 112,744 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $4,671,604 | 128,943 | Shares | Defined | 2021-05-04 | |
| 2020-12-31 | $12,159,447 | 330,330 | Shares | Defined | 2021-02-01 | |
| 2020-09-30 | $7,526,318 | 205,077 | Shares | Defined | 2020-10-21 | |
| 2020-06-30 | $847,911 | 25,930 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $856,603 | 26,244 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||